These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30468974)

  • 1. Novel therapeutics in the treatment of hairy cell leukemia variant.
    Letendre P; Doll D
    Leuk Res; 2018 Dec; 75():58-60. PubMed ID: 30468974
    [No Abstract]   [Full Text] [Related]  

  • 2. Combo Therapy Effective for Relapsed CLL.
    Cancer Discov; 2015 Jul; 5(7):OF8. PubMed ID: 26034053
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
    Imoto N; Koyama D; Sugiura I; Kurahashi S
    Medicine (Baltimore); 2021 Feb; 100(5):e24457. PubMed ID: 33592897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
    Woyach JA; Ruppert AS; Heerema NA; Zhao W; Booth AM; Ding W; Bartlett NL; Brander DM; Barr PM; Rogers KA; Parikh SA; Coutre S; Hurria A; Brown JR; Lozanski G; Blachly JS; Ozer HG; Major-Elechi B; Fruth B; Nattam S; Larson RA; Erba H; Litzow M; Owen C; Kuzma C; Abramson JS; Little RF; Smith SE; Stone RM; Mandrekar SJ; Byrd JC
    N Engl J Med; 2018 Dec; 379(26):2517-2528. PubMed ID: 30501481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of mantle cell lymphoma relapsed or refractory chronic lymphocytic leukaemia.
    Prescrire Int; 2016 Apr; 25(170):91. PubMed ID: 27186618
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and Safety of Bendamustine and Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia: Indirect Comparison.
    Andrasiak I; Rybka J; Knopinska-Posluszny W; Wrobel T
    Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):268-273. PubMed ID: 28395851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases.
    Eren R; Suyanı E
    Turk J Haematol; 2018 Nov; 35(4):312-313. PubMed ID: 29983407
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of novel agents on patient-relevant outcomes in patients with previously untreated chronic lymphocytic leukemia who are not eligible for fludarabine-based therapy.
    Singh M; Mealing S; Baculea S; Cote S; Whelan J
    J Med Econ; 2017 Oct; 20(10):1066-1073. PubMed ID: 28720054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibrutinib for relapsed refractory hairy cell leukemia variant.
    Bohn JP; Wanner D; Steurer M
    Leuk Lymphoma; 2017 May; 58(5):1224-1226. PubMed ID: 27733095
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in the treatment of chronic lymphocytic leukemia from the 2014 meeting of the American Society of Hematology.
    Molica S
    Expert Rev Hematol; 2015 Jun; 8(3):277-81. PubMed ID: 25804936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a comprehensive chronic lymphocytic leukemia clinic at a tertiary referral center in India.
    Lad DP; Tejaswi V; Malhotra P; Varma N; Sachdeva MS; Naseem S; Sreedharanunni S; Prakash G; Khadwal A; Varma S
    Blood Adv; 2018 Nov; 2(Suppl 1):33-34. PubMed ID: 30504196
    [No Abstract]   [Full Text] [Related]  

  • 12. Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia.
    Tam CS; Trotman J; Opat S; Stern JC; Allewelt H; By K; Novotny W; Huang J; Tedeschi A
    Blood Adv; 2023 Jun; 7(12):2884-2887. PubMed ID: 36753605
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of rituximab in hairy cell leukemia].
    Malfuson JV; Doghmi K; Fagot T; Souleau B; De Revel T; Nedellec G
    Presse Med; 2006 May; 35(5 Pt 1):801-2. PubMed ID: 16710151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
    Talaulikar D; Tam CS; Joshua D; Ho JP; Szer J; Quach H; Spencer A; Harrison S; Mollee P; Roberts AW; Horvath N; Lee C; Zannettino A; Brown R; Augustson B; Jaksic W; Gibson J; Kalff A; Johnston A; Trotman J; Kalro A; Grigoriadis G; Ward C; Prince HM
    Intern Med J; 2017 Jan; 47(1):35-49. PubMed ID: 28076910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of hairy cell leukemia to bendamustine.
    Kreitman RJ; Arons E; Stetler-Stevenson M; Miller KB
    Leuk Lymphoma; 2011 Jun; 52(6):1153-6. PubMed ID: 21463128
    [No Abstract]   [Full Text] [Related]  

  • 16. Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational Study.
    Ninkovic M; Fiegl M; Mian M; Mondello P; Kocher F; Waldthaler C; Verdorfer I; Steurer M; Gastl G; Pircher A
    Anticancer Res; 2015 Sep; 35(9):5129-39. PubMed ID: 26254418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment of refractory hairy cell leukemia with rituximab].
    Onaka T; Ozumi N; Yonezawa A; Imada K
    Nihon Naika Gakkai Zasshi; 2009 Aug; 98(8):1987-9. PubMed ID: 19764485
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of rituximab in hairy cell leukemia treatment.
    Zinzani PL; Ascani S; Piccaluga PP; Bendandi M; Pileri S; Tura S
    J Clin Oncol; 2000 Nov; 18(22):3875-7. PubMed ID: 11078503
    [No Abstract]   [Full Text] [Related]  

  • 19. The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma.
    Laribi K; Tempescul A; Ghnaya H; Denizon N; Besançon A; Anghel A; Farhi J; Truong C; Lemaire P; Poulain S; Bolle D; Ianotto JC; Baugier de Materre A
    Hematol Oncol; 2017 Dec; 35(4):536-541. PubMed ID: 27443419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of hairy cell leukemia variant with rituximab.
    Narat S; Gandla J; Dogan A; Mehta A
    Leuk Lymphoma; 2005 Aug; 46(8):1229-32. PubMed ID: 16085567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.